Skip to content

Main Navigation

Mercia Ventures
  • Portfolio
  • Sectors
    • Software & AI
    • Health & Life Sciences
    • Consumer
    • Deep Tech
  • Team
  • Spotlight
  • Thoughts
  • Looking for investment

Author: Amy Westwood

Profile picture of Amy Westwood

Posts by Amy Westwood

Why we invested: UBI

Posted on February 3, 2026 (February 3, 2026)

UB Infrastructure (UBI) is a dynamic, fast-growing business that’s not just bucking market trends, but actively redefining what’s possible in the built environment. In a sector where productivity has been stubbornly declining, UBI’s tangible outputs are a breath of fresh air, setting new standards for manufactured buildings in infrastructure projects. Founders Charlie Davies and Ross

Posted in Spotlight, Why we invested

Why we invested: HTMS

Posted on January 14, 2026

Why we invested in HTMS – With Shubham Jaipuria When we first delved into the history of Danilo and Richard, they didn’t start out in a lab or a factory; they were in their kitchen. Two founders experimenting with Ceramic Matrix Composites (CMCs) on a kitchen table, driven by curiosity and a belief that these

Posted in Spotlight, Why we invested

Why we invested: Forge Genetics

Posted on January 7, 2026 (January 7, 2026)

Over the summer 2025, we invested £2m in Forge Genetics, a University of Nottingham spinout with a novel genetic engineering platform to rival CRISPR. Since 2013, labs around the world have relied on CRISPR-Cas9 for precise genome editing, enabling scientists to better understand diseases and develop new life-changing treatments. While undoubtedly opening the door for

Posted in Spotlight, Why we invested

Why we invested: NuVision

Posted on December 15, 2025 (December 15, 2025)

Last year we led a £3.2m Series A into NuVision, a Nottingham-based biotech producing innovative ocular therapies from human tissue. Since our initial investment into the newly formed spinout in 2015, NuVision has shipped over 15,000 treatments and expanded to multiple markets across Europe and the Middle East. NuVision’s products harness the impressive regenerative properties

Posted in Spotlight, Why we invested

Recent Posts

  • Why we invested: UBI
  • The Deal 2026
  • The Deal 2026: A review of 2025 equity deals
  • Why we invested: HTMS
  • Why we invested: Forge Genetics

Recent Comments

    Archives

    • February 2026
    • January 2026
    • December 2025
    • September 2025
    • August 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • September 2023
    • August 2023
    • July 2023
    • June 2023
    • April 2023
    • February 2023
    • January 2023
    • November 2022
    • October 2022
    • September 2022
    • August 2022
    • July 2022
    • June 2022
    • May 2022
    • April 2022
    • March 2022
    • January 2022
    • December 2021
    • September 2021
    • August 2021
    • July 2021
    • June 2021
    • May 2021
    • April 2021
    • March 2021
    • February 2021
    • January 2021
    • December 2020
    • November 2020
    • October 2020
    • September 2020
    • August 2020
    • July 2020
    • June 2020
    • May 2020
    • April 2020
    • March 2020
    • February 2020
    • January 2020
    • July 2019
    • March 2019
    • January 2019
    • October 2018
    • January 2017
    • December 2016

    Categories

    • Archive
    • Panel discussions
    • Spotlight
    • Thoughts
    • Videos
    • Webinars
    • Why we invested

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    © 2026 Mercia Ventures is a trading name of investment funds managed by Mercia Fund Management Limited and Mercia Regional Ventures Limited.

    • Privacy Policy
    • Terms & Conditions
    • Diversity, Equity & Inclusion Policy
    • Modern Slavery Statement

    Mercia Asset Management PLC is registered in England and Wales: 09223445. Its subsidiaries, Mercia Fund Management Limited, Mercia Regional Ventures Limited, Mercia Business Loans Limited and Frontier Development Capital Limited are authorised and regulated by the Financial Conduct Authority.

    Loading...
    Loading...